Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

2.

Impact of an information campaign on delays and ambulance use in acute coronary syndrome.

Thuresson M, Haglund P, Ryttberg B, Herlitz J, Nilsson U.

Am J Emerg Med. 2015 Feb;33(2):297-8. doi: 10.1016/j.ajem.2014.11.001. Epub 2014 Nov 8. No abstract available.

PMID:
25497696
3.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

4.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

5.

[Current patient records systems not sufficient as a basis for ranking lists].

Ryttberg B, Nyström E, Stenberg A, Palm K, Näslund I.

Lakartidningen. 2009 Oct 7-13;106(41):2623. Swedish. No abstract available.

PMID:
19927929
6.

["Open comparisons" no reliable measures of the quality of care in myocardial infarction. The epidemiological registry is not sufficient for county comparisons].

Ryttberg B, Nyström E, Stenberg A, Palm K, Näslund I.

Lakartidningen. 2009 Aug 26-Sep 1;106(35):2121-4. Swedish. No abstract available.

PMID:
19827376
7.

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

APPRAISE Steering Committee and Investigators, Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L.

Circulation. 2009 Jun 9;119(22):2877-85. doi: 10.1161/CIRCULATIONAHA.108.832139. Epub 2009 May 26.

8.

[Streptokinase in acute myocardial infarction].

Malmcrona R, Ryttberg B, Stjerna A.

Lakartidningen. 1985 Nov 27;82(48):4212-4. Swedish. No abstract available.

PMID:
4079605
9.

[Intravenous streptokinase in acute myocardial infarct].

Ryttberg B, Stjerna A, Johnsson KA, Malmcrona R.

Lakartidningen. 1984 Jun 27;81(26-27):2600-3. Swedish. No abstract available.

PMID:
6738254

Supplemental Content

Loading ...
Support Center